How about AstraZeneca, Pfizer and GlaxoSmithKline? Which group is the best, which group is average, and is there a big difference in development?

What the man above said about Pfizer is correct.

However, when Lipitor's patent expires at 20 1 1, domestic imitations will develop wildly. Although it was a good medicine, after the patent expired, the company drastically cut costs, lowered drug prices and increased indicators, which made the delegates miserable. Although it is now the second largest group of Pfizer, it will definitely be abolished after next year. Don't go to this group.

Special drug 1 antibiotic group: Shupushen, Dafukang, Yanzi and Fan Wei. The latter two drugs were newly listed in China and were killed in the domestic market in 2009, especially in Fan Wei. During the SARS period, there were no drugs in China, but they were introduced directly from the United States through special approval from the state. Imagine how good this is, and why there were Scorsese and Fan Wei in China at that time. For swallows, vancomycin, which is much more effective and safer than the same indication, is developing rapidly and has a good prospect.

Two groups of special drugs: tazocin, histamine and methylprednisolone. I wonder if the doctor took the wrong medicine or something. Methylprednisolone is used even if no one does it. If someone succeeds, they don't need prednisone at all. Xishumei has Xiaoer Granule. Nowadays, parents attach great importance to their children. If they cough, of course, they choose to import good medicine, so this group is super good.

Other groups are average and have no absolute advantage. Viagra is good, but the main reason is that there are too many retails.

AstraZeneca: Two good drugs, Xinbike Dubao and Rosicky, one for asthma and the other for gastric ulcer and acute gastric bleeding. The advantages of these two drugs in competitive products are not one or two, but absolute.

Other groups, including cardiovascular groups, are too competitive, and the investment may not be rewarded accordingly, so it is difficult to do it. Because cardiologists have been fed like pigs by major companies, as long as the money is in place, whether you are good or not.

GlaxoSmithKline, also known as GSK and shit K, needless to say, the company has no corporate culture. All the wolves can stay, but all the dogs can't.

If you choose the company first, I suggest Pfizer. It's an exaggeration to say that you only need to give you toilet paper money at Pfizer. The welfare is quite good.